BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Erauskin J, Fourcade S, Galino J, Ruiz M, Schlüter A, Naudi A, Jove M, Portero-Otin M, Pamplona R, Ferrer I, Pujol A. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol 2011;70:84-92. [PMID: 21786300 DOI: 10.1002/ana.22363] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Fransen M, Nordgren M, Wang B, Apanasets O, Van Veldhoven PP. Aging, Age-Related Diseases and Peroxisomes. In: del Río LA, editor. Peroxisomes and their Key Role in Cellular Signaling and Metabolism. Dordrecht: Springer Netherlands; 2013. pp. 45-65. [DOI: 10.1007/978-94-007-6889-5_3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
2 López-Erauskin J, Galino J, Ruiz M, Cuezva JM, Fabregat I, Cacabelos D, Boada J, Martínez J, Ferrer I, Pamplona R, Villarroya F, Portero-Otín M, Fourcade S, Pujol A. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. Hum Mol Genet 2013;22:3296-305. [PMID: 23604518 DOI: 10.1093/hmg/ddt186] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 8.0] [Reference Citation Analysis]
3 Wu Y, Huang Q, Liu X, Wei X. Dl-3-n-butylphthalide is effective for demyelination: A case-combined study. Clinical Neurology and Neurosurgery 2015;137:83-8. [DOI: 10.1016/j.clineuro.2015.06.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014;98:135-142. [PMID: 24316281 DOI: 10.1016/j.biochi.2013.11.023] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 11.2] [Reference Citation Analysis]
5 Carvalho KS. Mitochondrial dysfunction in demyelinating diseases. Semin Pediatr Neurol 2013;20:194-201. [PMID: 24331361 DOI: 10.1016/j.spen.2013.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
6 Deon M, Marchetti DP, Donida B, Wajner M, Vargas C. Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy. Cell Mol Neurobiol 2016;36:497-512. [DOI: 10.1007/s10571-015-0234-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
7 Matalonga L, Arias A, Coll MJ, Garcia-villoria J, Gort L, Ribes A. Treatment effect of coenzyme Q10 and an antioxidant cocktail in fibroblasts of patients with Sanfilippo disease. J Inherit Metab Dis 2014;37:439-46. [DOI: 10.1007/s10545-013-9668-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
8 Morató L, Galino J, Ruiz M, Calingasan NY, Starkov AA, Dumont M, Naudí A, Martínez JJ, Aubourg P, Portero-Otín M, Pamplona R, Galea E, Beal MF, Ferrer I, Fourcade S, Pujol A. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Brain 2013;136:2432-43. [PMID: 23794606 DOI: 10.1093/brain/awt143] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
9 Signorini C, De Felice C, Durand T, Galano J, Oger C, Leoncini S, Hayek J, Lee JC, Lund TC, Orchard PJ. Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease. Life 2022;12:146. [DOI: 10.3390/life12020146] [Reference Citation Analysis]
10 Fransen M, Nordgren M, Wang B, Apanasets O. Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012;1822:1363-73. [DOI: 10.1016/j.bbadis.2011.12.001] [Cited by in Crossref: 296] [Cited by in F6Publishing: 277] [Article Influence: 29.6] [Reference Citation Analysis]
11 Farr RL, Lismont C, Terlecky SR, Fransen M. Peroxisome biogenesis in mammalian cells: The impact of genes and environment. Biochim Biophys Acta 2016;1863:1049-60. [PMID: 26305119 DOI: 10.1016/j.bbamcr.2015.08.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
12 Manor J, Chung H, Bhagwat PK, Wangler MF. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models. J Neurosci Res 2021. [PMID: 34716609 DOI: 10.1002/jnr.24953] [Reference Citation Analysis]
13 Honey MIJ, Jaspers YRJ, Engelen M, Kemp S, Huffnagel IC. Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need. Cells 2021;10:3427. [PMID: 34943935 DOI: 10.3390/cells10123427] [Reference Citation Analysis]
14 Zhou J, Terluk MR, Orchard PJ, Cloyd JC, Kartha RV. N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy. Biomedicines 2021;9:1826. [PMID: 34944641 DOI: 10.3390/biomedicines9121826] [Reference Citation Analysis]
15 Karuppagounder SS, Alin L, Chen Y, Brand D, Bourassa MW, Dietrich K, Wilkinson CM, Nadeau CA, Kumar A, Perry S, Pinto JT, Darley-Usmar V, Sanchez S, Milne GL, Pratico D, Holman TR, Carmichael ST, Coppola G, Colbourne F, Ratan RR. N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice. Ann Neurol 2018;84:854-72. [PMID: 30294906 DOI: 10.1002/ana.25356] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 15.8] [Reference Citation Analysis]
16 Baarine M, Khan M, Singh A, Singh I. Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy. PLoS One 2015;10:e0143238. [PMID: 26581106 DOI: 10.1371/journal.pone.0143238] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
17 López-Erauskin J, Galino J, Bianchi P, Fourcade S, Andreu AL, Ferrer I, Muñoz-Pinedo C, Pujol A. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain 2012;135:3584-98. [PMID: 23250880 DOI: 10.1093/brain/aws292] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
18 Nury T, Zarrouk A, Ragot K, Debbabi M, Riedinger JM, Vejux A, Aubourg P, Lizard G. 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: Potential roles of 7-ketocholesterol in the pathophysiology of X-ALD. J Steroid Biochem Mol Biol. 2017;169:123-136. [PMID: 27041118 DOI: 10.1016/j.jsbmb.2016.03.037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
19 Fourcade S, Ferrer I, Pujol A. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration. Free Radic Biol Med 2015;88:18-29. [PMID: 26073123 DOI: 10.1016/j.freeradbiomed.2015.05.041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
20 Gallego-Villar L, Pérez-Cerdá C, Pérez B, Abia D, Ugarte M, Richard E, Desviat LR. Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia. J Inherit Metab Dis 2013;36:731-40. [PMID: 23053474 DOI: 10.1007/s10545-012-9545-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
21 Conforti L, Gilley J, Coleman MP. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 2014;15:394-409. [DOI: 10.1038/nrn3680] [Cited by in Crossref: 316] [Cited by in F6Publishing: 290] [Article Influence: 39.5] [Reference Citation Analysis]
22 Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy – neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol 2016;12:606-15. [DOI: 10.1038/nrendo.2016.90] [Cited by in Crossref: 113] [Cited by in F6Publishing: 81] [Article Influence: 18.8] [Reference Citation Analysis]
23 Bargiela D, Eglon G, Horvath R, Chinnery PF. An under-recognised cause of spastic paraparesis in middle-aged women. Pract Neurol 2014;14:182-4. [PMID: 24154795 DOI: 10.1136/practneurol-2013-000662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Raymond GV. Leukodystrophy: Basic and Clinical. In: Beart P, Robinson M, Rattray M, Maragakis NJ, editors. Neurodegenerative Diseases. Cham: Springer International Publishing; 2017. pp. 365-82. [DOI: 10.1007/978-3-319-57193-5_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Stepien KM, Heaton R, Rankin S, Murphy A, Bentley J, Sexton D, Hargreaves IP. Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders. J Clin Med 2017;6:E71. [PMID: 28753922 DOI: 10.3390/jcm6070071] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 9.6] [Reference Citation Analysis]
26 Rice CM, Sun M, Kemp K, Gray E, Wilkins A, Scolding NJ. Mitochondrial sirtuins - a new therapeutic target for repair and protection in multiple sclerosis: Mitochondrial sirtuins in MS. European Journal of Neuroscience 2012;35:1887-93. [DOI: 10.1111/j.1460-9568.2012.08150.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
27 Janc OA, Hüser MA, Dietrich K, Kempkes B, Menzfeld C, Hülsmann S, Müller M. Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox. Front Cell Neurosci 2016;10:266. [PMID: 27895554 DOI: 10.3389/fncel.2016.00266] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
28 Schönfeld P, Reiser G. How the brain fights fatty acids' toxicity. Neurochem Int 2021;148:105050. [PMID: 33945834 DOI: 10.1016/j.neuint.2021.105050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ruiz M, Bégou M, Launay N, Ranea-Robles P, Bianchi P, López-Erauskin J, Morató L, Guilera C, Petit B, Vaurs-Barriere C, Guéret-Gonthier C, Bonnet-Dupeyron MN, Fourcade S, Auwerx J, Boespflug-Tanguy O, Pujol A. Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease. Brain Pathol 2018;28:611-30. [PMID: 29027761 DOI: 10.1111/bpa.12571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
30 Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The BT. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 2012;7:51. [PMID: 22889154 DOI: 10.1186/1750-1172-7-51] [Cited by in Crossref: 227] [Cited by in F6Publishing: 191] [Article Influence: 22.7] [Reference Citation Analysis]
31 Turk BR, Theda C, Fatemi A, Moser AB. X-linked Adrenoleukodystrophy: Pathology, Pathophysiology, Diagnostic Testing, Newborn Screening, and Therapies. International Journal of Developmental Neuroscience 2019. [DOI: 10.1016/j.ijdevneu.2019.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
32 Fourcade S, Goicoechea L, Parameswaran J, Schlüter A, Launay N, Ruiz M, Seyer A, Colsch B, Calingasan NY, Ferrer I, Beal MF, Sedel F, Pujol A. High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy. Brain Pathol 2020;30:945-63. [PMID: 32511826 DOI: 10.1111/bpa.12869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Fourcade S, López-Erauskin J, Ruiz M, Ferrer I, Pujol A. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy. Biochimie 2014;98:143-9. [PMID: 24076127 DOI: 10.1016/j.biochi.2013.09.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
34 Rodríguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S, Weinhofer I, Bauer J, Kemp S, Pina G, Pascual S, Meya U, Musolino PL, Berger J, Martinell M, Pizcueta P. The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy. Sci Transl Med 2021;13:eabc0555. [PMID: 34078742 DOI: 10.1126/scitranslmed.abc0555] [Reference Citation Analysis]
35 Ray SK, Mukherjee S. Molecular and biochemical investigations of inborn errors of metabolism-altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Free Radic Res 2021;:1-14. [PMID: 33504220 DOI: 10.1080/10715762.2021.1877286] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Nury T, Doria M, Lizard G, Vejux A. Docosahexaenoic Acid Attenuates Mitochondrial Alterations and Oxidative Stress Leading to Cell Death Induced by Very Long-Chain Fatty Acids in a Mouse Oligodendrocyte Model. Int J Mol Sci 2020;21:E641. [PMID: 31963714 DOI: 10.3390/ijms21020641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 Morató L, Bertini E, Verrigni D, Ardissone A, Ruiz M, Ferrer I, Uziel G, Pujol A. Mitochondrial dysfunction in central nervous system white matter disorders: Mitochondrial Dysfunction in Brain White Matter. Glia 2014;62:1878-94. [DOI: 10.1002/glia.22670] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
38 Ruiz M, Jové M, Schlüter A, Casasnovas C, Villarroya F, Guilera C, Ortega FJ, Naudí A, Pamplona R, Gimeno R, Fourcade S, Portero-Otín M, Pujol A. Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. Hum Mol Genet 2015;24:6861-76. [PMID: 26370417 DOI: 10.1093/hmg/ddv375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
39 Yu J, Chen T, Guo X, Zafar MI, Li H, Wang Z, Zheng J. The Role of Oxidative Stress and Inflammation in X-Link Adrenoleukodystrophy. Front Nutr 2022;9:864358. [DOI: 10.3389/fnut.2022.864358] [Reference Citation Analysis]
40 Launay N, Aguado C, Fourcade S, Ruiz M, Grau L, Riera J, Guilera C, Giròs M, Ferrer I, Knecht E, Pujol A. Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy. Acta Neuropathol 2015;129:399-415. [PMID: 25549970 DOI: 10.1007/s00401-014-1378-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
41 Launay N, Ruiz M, Grau L, Ortega FJ, Ilieva EV, Martínez JJ, Galea E, Ferrer I, Knecht E, Pujol A, Fourcade S. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy. Acta Neuropathol 2017;133:283-301. [PMID: 28004277 DOI: 10.1007/s00401-016-1655-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
42 Debbabi M, Nury T, Zarrouk A, Mekahli N, Bezine M, Sghaier R, Grégoire S, Martine L, Durand P, Camus E, Vejux A, Jabrane A, Bretillon L, Prost M, Moreau T, Ammou SB, Hammami M, Lizard G. Protective Effects of α-Tocopherol, γ-Tocopherol and Oleic Acid, Three Compounds of Olive Oils, and No Effect of Trolox, on 7-Ketocholesterol-Induced Mitochondrial and Peroxisomal Dysfunction in Microglial BV-2 Cells. Int J Mol Sci 2016;17:E1973. [PMID: 27897980 DOI: 10.3390/ijms17121973] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
43 Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012;1822:1465-74. [DOI: 10.1016/j.bbadis.2012.03.012] [Cited by in Crossref: 155] [Cited by in F6Publishing: 132] [Article Influence: 15.5] [Reference Citation Analysis]
44 Vantyghem MC, Dobbelaere D, Mention K, Wemeau JL, Saudubray JM, Douillard C. Endocrine manifestations related to inherited metabolic diseases in adults. Orphanet J Rare Dis 2012;7:11. [PMID: 22284844 DOI: 10.1186/1750-1172-7-11] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
45 Turk BR, Nemeth CL, Marx JS, Tiffany C, Jones R, Theisen B, Kambhampati S, Ramireddy R, Singh S, Rosen M, Kaufman ML, Murray CF, Watkins PA, Kannan S, Kannan R, Fatemi A. Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy. Ann Neurol 2018;84:452-62. [PMID: 30069915 DOI: 10.1002/ana.25303] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
46 De Felice C, Signorini C, Durand T, Ciccoli L, Leoncini S, D'Esposito M, Filosa S, Oger C, Guy A, Bultel-Poncé V, Galano JM, Pecorelli A, De Felice L, Valacchi G, Hayek J. Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr 2012;7:447-58. [PMID: 22399313 DOI: 10.1007/s12263-012-0285-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 6.4] [Reference Citation Analysis]
47 Orchard PJ, Markowski TW, Higgins L, Raymond GV, Nascene DR, Miller WP, Pierpont EI, Lund TC. Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy. Sci Rep. 2019;9:7858. [PMID: 31133696 DOI: 10.1038/s41598-019-44140-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Schlüter A, Espinosa L, Fourcade S, Galino J, López E, Ilieva E, Morató L, Asheuer M, Cook T, McLaren A, Reid J, Kelly F, Bates S, Aubourg P, Galea E, Pujol A. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy. Hum Mol Genet 2012;21:1062-77. [PMID: 22095690 DOI: 10.1093/hmg/ddr536] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
49 Ranea-Robles P, Launay N, Ruiz M, Calingasan NY, Dumont M, Naudí A, Portero-Otín M, Pamplona R, Ferrer I, Beal MF, Fourcade S, Pujol A. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO Mol Med 2018;10:e8604. [PMID: 29997171 DOI: 10.15252/emmm.201708604] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
50 Montoro R, Heine VM, Kemp S, Engelen M. Evolution of adrenoleukodystrophy model systems. J Inherit Metab Dis 2021;44:544-53. [PMID: 33373044 DOI: 10.1002/jimd.12357] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Murillo-Cuesta S, Artuch R, Asensio F, de la Villa P, Dierssen M, Enríquez JA, Fillat C, Fourcade S, Ibáñez B, Montoliu L, Oliver E, Pujol A, Salido E, Vallejo M, Varela-Nieto I. The Value of Mouse Models of Rare Diseases: A Spanish Experience. Front Genet 2020;11:583932. [PMID: 33173540 DOI: 10.3389/fgene.2020.583932] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Morita M, Imanaka T. Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta. 2012;1822:1387-1396. [PMID: 22366764 DOI: 10.1016/j.bbadis.2012.02.009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 10.3] [Reference Citation Analysis]
53 Malaguti M, Cardenia V, Rodriguez-estrada MT, Hrelia S. Nutraceuticals and physical activity: Their role on oxysterols-mediated neurodegeneration. The Journal of Steroid Biochemistry and Molecular Biology 2019;193:105430. [DOI: 10.1016/j.jsbmb.2019.105430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Geillon F, Trompier D, Gondcaille C, Lizard G, Savary S. Transporteurs ABC peroxysomaux et adrénoleucodystrophie liée au chromosome X. Med Sci (Paris) 2012;28:1087-94. [DOI: 10.1051/medsci/20122812019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
55 Lismont C, Nordgren M, Van Veldhoven PP, Fransen M. Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol 2015;3:35. [PMID: 26075204 DOI: 10.3389/fcell.2015.00035] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 15.1] [Reference Citation Analysis]
56 Morató L, Ruiz M, Boada J, Calingasan NY, Galino J, Guilera C, Jové M, Naudí A, Ferrer I, Pamplona R, Serrano M, Portero-Otín M, Beal MF, Fourcade S, Pujol A. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy. Cell Death Differ 2015;22:1742-53. [PMID: 25822341 DOI: 10.1038/cdd.2015.20] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
57 Coppa A, Guha S, Fourcade S, Parameswaran J, Ruiz M, Moser AB, Schlüter A, Murphy MP, Lizcano JM, Miranda-Vizuete A, Dalfó E, Pujol A. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy. Free Radic Biol Med 2020;152:797-809. [PMID: 32017990 DOI: 10.1016/j.freeradbiomed.2020.01.177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
58 Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, Cappa M, Bertini E. Glutathione imbalance in patients with X-linked adrenoleukodystrophy. Mol Genet Metab 2013;109:366-70. [PMID: 23768953 DOI: 10.1016/j.ymgme.2013.05.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
59 Marchetti DP, Donida B, da Rosa HT, Manini PR, Moura DJ, Saffi J, Deon M, Mescka CP, Coelho DM, Jardim LB, Vargas CR. Protective effect of antioxidants on DNA damage in leukocytes from X-linked adrenoleukodystrophy patients. Int J Dev Neurosci 2015;43:8-15. [PMID: 25765338 DOI: 10.1016/j.ijdevneu.2015.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
60 Turk BR, Moser AB, Fatemi A. Therapeutic strategies in adrenoleukodystrophy. Wien Med Wochenschr 2017;167:219-26. [PMID: 28493141 DOI: 10.1007/s10354-016-0534-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
61 Miranda CO, Brites P, Mendes Sousa M, Teixeira CA. Advances and pitfalls of cell therapy in metabolic leukodystrophies. Cell Transplant 2013;22:189-204. [PMID: 23006656 DOI: 10.3727/096368912X656117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Ferrer I, López-Gonzalez I, Carmona M, Dalfó E, Pujol A, Martínez A. Neurochemistry and the non-motor aspects of PD. Neurobiol Dis 2012;46:508-26. [PMID: 22737710 DOI: 10.1016/j.nbd.2011.10.019] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
63 Patel S, Gutowski N. The difficulty in diagnosing X linked adrenoleucodystrophy and the importance of identifying cerebral involvement. BMJ Case Rep 2015;2015:bcr2015209732. [PMID: 25969497 DOI: 10.1136/bcr-2015-209732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Jangouk P, Zackowski KM, Naidu S, Raymond GV. Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated. Mol Genet Metab. 2012;105:180-185. [PMID: 22112817 DOI: 10.1016/j.ymgme.2011.11.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
65 Vapola MH, Rokka A, Sormunen RT, Alhonen L, Schmitz W, Conzelmann E, Wärri A, Grunau S, Antonenkov VD, Hiltunen JK. Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice. Dev Biol 2014;391:66-80. [PMID: 24726525 DOI: 10.1016/j.ydbio.2014.03.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
66 Ma CY, Li C, Zhou X, Zhang Z, Jiang H, Liu H, Chen HJ, Tse HF, Liao C, Lian Q. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies. Biomed Pharmacother 2021;143:112214. [PMID: 34560537 DOI: 10.1016/j.biopha.2021.112214] [Reference Citation Analysis]
67 Kartha RV, Zhou J, Basso L, Schröder H, Orchard PJ, Cloyd J. Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy. CNS Drugs 2015;29:1041-7. [PMID: 26670322 DOI: 10.1007/s40263-015-0300-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
68 Ciccoli L, De Felice C, Paccagnini E, Leoncini S, Pecorelli A, Signorini C, Belmonte G, Valacchi G, Rossi M, Hayek J. Morphological changes and oxidative damage in Rett Syndrome erythrocytes. Biochimica et Biophysica Acta (BBA) - General Subjects 2012;1820:511-20. [DOI: 10.1016/j.bbagen.2011.12.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
69 Hama K, Fujiwara Y, Takashima S, Hayashi Y, Yamashita A, Shimozawa N, Yokoyama K. Hexacosenoyl-CoA is the most abundant very long-chain acyl-CoA in ATP binding cassette transporter D1-deficient cells. J Lipid Res 2020;61:523-36. [PMID: 32075856 DOI: 10.1194/jlr.P119000325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
70 Bottelbergs A, Verheijden S, Van Veldhoven PP, Just W, Devos R, Baes M. Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system. J Neuroinflammation 2012;9:61. [PMID: 22458306 DOI: 10.1186/1742-2094-9-61] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
71 Verheijden S, Beckers L, De Munter S, Van Veldhoven PP, Baes M. Central nervous system pathology in MFP2 deficiency: Insights from general and conditional knockout mouse models. Biochimie 2014;98:119-26. [DOI: 10.1016/j.biochi.2013.08.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
72 정을식, 강훈철, 고아라. X-linked adrenoleukodystrophy; Recent Advances in Classification, Diagnosis and Management. journalofthekoreanchildneurologysociety 2016;24:71-83. [DOI: 10.26815/jkcns.2016.24.3.71] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Jang J, Park S, Jin Hur H, Cho HJ, Hwang I, Pyo Kang Y, Im I, Lee H, Lee E, Yang W, Kang HC, Won Kwon S, Yu JW, Kim DW. 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome. Nat Commun. 2016;7:13129. [PMID: 27779191 DOI: 10.1038/ncomms13129] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 12.3] [Reference Citation Analysis]
74 Turk BR, Theda C, Fatemi A, Moser AB. X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci 2020;80:52-72. [PMID: 31909500 DOI: 10.1002/jdn.10003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
75 Richard E, Gallego-Villar L, Rivera-Barahona A, Oyarzábal A, Pérez B, Rodríguez-Pombo P, Desviat LR. Altered Redox Homeostasis in Branched-Chain Amino Acid Disorders, Organic Acidurias, and Homocystinuria. Oxid Med Cell Longev 2018;2018:1246069. [PMID: 29743968 DOI: 10.1155/2018/1246069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
76 Zuo L, Motherwell MS. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson’s disease. Gene. 2013;532:18-23. [PMID: 23954870 DOI: 10.1016/j.gene.2013.07.085] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 13.3] [Reference Citation Analysis]
77 Szczesna K, de la Caridad O, Petazzi P, Soler M, Roa L, Saez MA, Fourcade S, Pujol A, Artuch-Iriberri R, Molero-Luis M, Vidal A, Huertas D, Esteller M. Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor. Neuropsychopharmacology 2014;39:2846-56. [PMID: 24917201 DOI: 10.1038/npp.2014.136] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
78 Nutma E, Marzin MC, Cillessen SA, Amor S. Autophagy in white matter disorders of the CNS: mechanisms and therapeutic opportunities. J Pathol 2021;253:133-47. [PMID: 33135781 DOI: 10.1002/path.5576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Haynes CA, De Jesús VR. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening. Clinica Chimica Acta 2012;413:1217-21. [DOI: 10.1016/j.cca.2012.03.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
80 Verheijden S, Bottelbergs A, Krysko O, Krysko DV, Beckers L, De Munter S, Van Veldhoven PP, Wyns S, Kulik W, Nave KA, Ramer MS, Carmeliet P, Kassmann CM, Baes M. Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation. Neurobiol Dis 2013;58:258-69. [PMID: 23777740 DOI: 10.1016/j.nbd.2013.06.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
81 Kruska N, Schönfeld P, Pujol A, Reiser G. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions. Biochim Biophys Acta 2015;1852:925-36. [PMID: 25583114 DOI: 10.1016/j.bbadis.2015.01.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
82 Baarine M, Andréoletti P, Athias A, Nury T, Zarrouk A, Ragot K, Vejux A, Riedinger J, Kattan Z, Bessede G, Trompier D, Savary S, Cherkaoui-malki M, Lizard G. Evidence of oxidative stress in very long chain fatty acid – Treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience 2012;213:1-18. [DOI: 10.1016/j.neuroscience.2012.03.058] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
83 Ferrer I. Sisyphus in Neverland. J Alzheimers Dis 2018;62:1023-47. [PMID: 29154280 DOI: 10.3233/JAD-170609] [Reference Citation Analysis]
84 Ranea-Robles P, Galino J, Espinosa L, Schlüter A, Ruiz M, Calingasan NY, Villarroya F, Naudí A, Pamplona R, Ferrer I, Beal MF, Portero-Otín M, Fourcade S, Pujol A. Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model. Neuropathol Appl Neurobiol 2021. [PMID: 34237158 DOI: 10.1111/nan.12747] [Reference Citation Analysis]
85 Galino J, Ruiz M, Fourcade S, Schlüter A, López-Erauskin J, Guilera C, Jove M, Naudi A, García-Arumí E, Andreu AL, Starkov AA, Pamplona R, Ferrer I, Portero-Otin M, Pujol A. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 2011;15:2095-107. [PMID: 21453200 DOI: 10.1089/ars.2010.3877] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
86 Tieu JH, Sahasrabudhe SA, Orchard PJ, Cloyd JC, Kartha RV. Translational and clinical pharmacology considerations in drug repurposing for X-linked adrenoleukodystrophy-A rare peroxisomal disorder. Br J Clin Pharmacol 2021. [PMID: 34558098 DOI: 10.1111/bcp.15090] [Reference Citation Analysis]
87 Launay N, Ruiz M, Fourcade S, Schlüter A, Guilera C, Ferrer I, Knecht E, Pujol A. Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy. Brain 2013;136:891-904. [PMID: 23436506 DOI: 10.1093/brain/aws370] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
88 Berger J, Dorninger F, Forss-Petter S, Kunze M. Peroxisomes in brain development and function. Biochim Biophys Acta 2016;1863:934-55. [PMID: 26686055 DOI: 10.1016/j.bbamcr.2015.12.005] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 12.7] [Reference Citation Analysis]
89 Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P, Ferrer I, Pujol A. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta 2012;1822:1475-88. [PMID: 22353463 DOI: 10.1016/j.bbadis.2012.02.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]